Impact BioMedical Inc.
IBO
Rank in Stocks
#24245
Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on... Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions. Additionally, "Laetose" technology, a unique blend of sugar and inositol, is designed to counteract the inflammatory and metabolic responses usually triggered by sugar consumption. Impact BioMedical also creates "functional fragrance formulations," which are a series of fragrances incorporating specialized botanical ingredients for antimicrobial purposes, or as active additives in items like insect repellents, cleaning products, personal care items, and fabrics. Rounding out its offerings is the "Equivir/Equivir G" technology, a distinctive mix of polyphenols that has exhibited antiviral properties, suitable for use in health supplements and medications.
Share Price
$4.01
Last synced: 2026-11-09
Market Cap
$34.65M
Change (1 day)
-2.43%
Change (1 year)
670.12%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Impact BioMedical Inc. (IBO)
Category
Healthcare
Operating Margin for Impact BioMedical Inc. (IBO)
Operating Margin as of November 2026 TTM: -14,562.86%
According to Impact BioMedical Inc.'s latest financial reports, its current operating margin (TTM) is -14,562.86%. At the end of 2025 the company had an operating margin of -13,343.75%.
Operating Margin history for Impact BioMedical Inc. from 2024 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -14,562.86% | 9.14% |
| 2025 | -13,343.75% | -56,474.10% |
| 2024 | 23.67% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.00% |
US
|
|
| -149.01% | -99.99% |
US
|
|
| 25.57% | -100.00% |
AU
|
|
| 31.23% | -100.00% |
BE
|
|
| 29.35% | -100.00% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Impact BioMedical Inc.'s operating margin
What is Impact BioMedical Inc.'s operating margin?
Impact BioMedical Inc.'s operating margin is -14,562.86%, as of Nov 2026.
What was Impact BioMedical Inc.'s operating margin in 2025?
In 2025, Impact BioMedical Inc.'s operating margin was -13,343.75%, compared with 23.67% in 2024.
How does Impact BioMedical Inc.'s operating margin compare with similar companies?
Impact BioMedical Inc.'s operating margin (-14,562.86%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.